U.S./EU device MRA implementation by FDA will rely on outside organizations.
This article was originally published in The Gray Sheet
U.S./EU MRA IMPLEMENTATION BY NON-FDA U.S. ASSESSMENT BODIES PLANNED by the agency, FDA staffers say. Given its resource limitations, FDA is seeking to outsource the European Union CE mark premarket evaluations and facility inspections for conformance to the EU's EN 46000 series quality systems standards mandated by the June device mutual recognition agreement (MRA).
You may also be interested in...
FDA's efforts to rely on outside support to carry out its mission have again met with resistance from House Appropriations Subcommittee Chair Rosa DeLauro, D-Conn., who is arguably the agency's most powerful public benefactor
BD and BioMedomics have released a new rapid point-of-care test that can detect antibodies in blood to confirm current or past exposure to COVID-19.